Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Capital Expenditures (2024 - 2025)

Historic Capital Expenditures for Zenas BioPharma (ZBIO) over the last 2 years, with Q1 2025 value amounting to $18000.0.

  • Zenas BioPharma's Capital Expenditures fell 1818.18% to $18000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $92000.0, marking a year-over-year change of. This contributed to the annual value of $131000.0 for FY2024, which is 67058.82% up from last year.
  • As of Q1 2025, Zenas BioPharma's Capital Expenditures stood at $18000.0, which was down 1818.18% from $74000.0 recorded in Q4 2024.
  • In the past 5 years, Zenas BioPharma's Capital Expenditures registered a high of $74000.0 during Q4 2024, and its lowest value of $18000.0 during Q1 2025.